Cubist Systematic Strategies, LLC Bridge Bio Pharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 2,800 shares of BBIO stock, worth $129,639. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,800

Previous 20,300 86.21%

Holding current value

$129,639

Previous $557,000 82.76%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $276,494 - $505,217	11,511 New	11,511 $464,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $446,318 - $604,829	-33,583 Reduced 15.36%	185,063 $3.18 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.52 Million - $3.93 Million	211,721 Added 3057.34%	218,646 $3.63 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $3.05 Million - $5.21 Million	-452,011 Reduced 98.49%	6,925 $52,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $1.73 Million - $2.69 Million	217,940 Added 90.43%	458,936 $4.56 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $29,879 - $69,622	-5,735 Reduced 2.32%	240,996 $2.19 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $1.35 Million - $3.15 Million	183,439 Added 289.83%	246,731 $2.5 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $587,845 - $2.76 Million	51,656 Added 443.93%	63,292 $1.06 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $545,379 - $747,496	11,636 New	11,636 $545,000
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $173,704 - $238,970	-3,738 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $232,308 - $303,001	-4,188 Reduced 52.84%	3,738 $230,000
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $801,182 - $1.48 Million	-20,875 Reduced 72.48%	7,926 $564,000
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $783,387 - $1.22 Million	28,801 New	28,801 $1.08 Million

Others Institutions Holding BBIO

# of Institutions

369

Shares Held

184M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $6.86B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Bridge Bio Pharma, Inc. Transaction History